Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Donna Mastey"'
Autor:
Neha Korde, Elizabet Tavitian, Donna Mastey, Joseph Lengfellner, Gil Hevroni, Andrew Zarski, Meghan Salcedo, Sham Mailankody, Hani Hassoun, Eric L. Smith, Malin Hultcrantz, Urvi Shah, Carlyn Tan, Benjamin Diamond, Gunjan Shah, Michael Scordo, Oscar Lahoud, David J. Chung, Heather Landau, Sergio Giralt, Andriy Derkach, Thomas M. Atkinson, Paul Sabbatini, Francesca König, Saad Z. Usmani, Ola Landgren, Alexander M. Lesokhin
Publikováno v:
EClinicalMedicine, Vol 57, Iss , Pp 101854- (2023)
Summary: Background: Due to the nature of their disease, patients with multiple myeloma (MM) often have bone disease-related pain that limits physical activity and diminishes health-related quality of life (HRQOL). Digital health technology with wear
Externí odkaz:
https://doaj.org/article/69e6fdb4a43d4fcba4fec6488dc5fbc2
Autor:
Matthew J. Pianko, Sean M. Devlin, Eric R. Littmann, Aisara Chansakul, Donna Mastey, Meghan Salcedo, Emily Fontana, Lilan Ling, Elizabet Tavitian, John B. Slingerland, Ann E. Slingerland, Annelie Clurman, Antonio L.C. Gomes, Ying Taur, Eric G. Pamer, Jonathan U. Peled, Marcel R.M. van den Brink, Ola Landgren, Alexander M. Lesokhin
Publikováno v:
Blood Advances, Vol 3, Iss 13, Pp 2040-2044 (2019)
Abstract: Patients with multiple myeloma (MM) who achieve minimal residual disease (MRD) negativity after upfront treatment have superior outcomes compared with those who remain MRD+. Recently, associations have been shown between specific commensal
Externí odkaz:
https://doaj.org/article/9883a042db834c8a806f8895e5db5018
Autor:
Amanda Ciardiello, Malin Hultcrantz, Jenna Rispoli, Benjamin Diamond, Urvi A Shah, Neha Korde, Sham Mailankody, Ola Landgren, Donna Mastey, Katie L. Thoren, Kelly Werner, Meghan Salcedo, Hani Hassoun, Eric L. Smith, Marion Eveillard, Alexander M. Lesokhin, Sydney X. Lu
Publikováno v:
Clin Chim Acta
BACKGROUND: Daratumumab-based combination therapies have shown high rates of complete response (CR) and minimal residual disease negativity in patients with multiple myeloma. However, daratumumab, an IgGκ monoclonal antibody, interferes with electro
Autor:
Malin Hultcrantz, Heather Landau, Sydney Lu, Sean M. Devlin, Ahmet Dogan, Sham Mailankody, Carlyn Tan, Michael Scordo, Oscar B Lahoud, Ola Landgren, Eric L. Smith, Meghan Salcedo, Caleb Ho, Urvi A Shah, Hani Hassoun, Neha Korde, Benjamin Diamond, Gunjan L. Shah, Donna Mastey, Maria E. Arcila, David J. Chung, Kelly Werner, Mikhail Roshal, Alexander M. Lesokhin, Andriy Derkach, Elizabet Tavitian, Sergio Giralt, Nikoletta Lendvai
Publikováno v:
American Journal of Hematology
Autor:
Neha Korde, Elizabeth Tavitian, Donna Mastey, Joseph Lengfellner, Gil Hevroni, Andrew Zarski, Meghan Salcedo, Sham Mailankody, Hani Hassoun, Eric L. Smith, Malin Hultcrantz, Urvi Shah, Carlyn Rose Tan, Benjamin Diamond, Gunjan Shah, Michael Scordo, Oscar B. Lahoud, David J. Chung, Heather J. Landau, Sergio A. Giralt, Andriy Derkach, Thomas Atkinson, Paul Sabbatini, Francesca Konig, Saad Usmani, Ola Landgren, Alexander Lesokhin
Publikováno v:
SSRN Electronic Journal.
Autor:
Lilan Ling, Donna Mastey, Antonio L.C. Gomes, Meghan Salcedo, Aisara Chansakul, Matthew J. Pianko, Eric R. Littmann, Eric G. Pamer, Emily Fontana, Elizabet Tavitian, Annelie Clurman, Sean M. Devlin, Ola Landgren, Alexander M. Lesokhin, John B. Slingerland, Ann E. Slingerland, Jonathan U. Peled, Marcel R.M. van den Brink, Ying Taur
Publikováno v:
Blood Advances. 3:2040-2044
Patients with multiple myeloma (MM) who achieve minimal residual disease (MRD) negativity after upfront treatment have superior outcomes compared with those who remain MRD+. Recently, associations have been shown between specific commensal microbes a
Autor:
Nikoletta Lendvai, Oscar B Lahoud, Hani Hassoun, Pamela Drullinsky, Gunjan L. Shah, Victoria Diab, Alexander M. Lesokhin, Donna Mastey, Heather Landau, Urvi A Shah, Malin Hultcrantz, Sham Mailankody, Ola Landgren, Sergio Giralt, Meghan Salcedo, Neha Korde, Eric L. Smith, Michael Scordo, David J. Chung, Julia Schlossman, Kelly Werner
Publikováno v:
Clin Lymphoma Myeloma Leuk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e67cb61a25106e82f0188cb09c5de1
https://europepmc.org/articles/PMC7405911/
https://europepmc.org/articles/PMC7405911/
Autor:
Elizabet Tavitian, Malin Hultcrantz, Sergio Giralt, Neha Korde, Alexander M. Lesokhin, Thomas M. Atkinson, Hani Hassoun, Carlyn Tan, Carl Ola Landgren, Donna Mastey, Andriy Derkach, Gunjan L. Shah, Joseph Lengfellner, Gil Hevroni, Sham Mailankody, Meghan Salcedo, Urvi A Shah, Sydney X. Lu, Eric L. Smith, Sean M. Devlin
Publikováno v:
Journal of Clinical Oncology. 39:8040-8040
8040 Background: Passive monitoring using wearables can objectively measure sleep over extended time periods. MM patients (PTs) are susceptible to fluctuating sleep patterns due to pain and dexamethasone (dex) treatment. In this prospective study, we
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael Scordo, Ahmet Dogan, Malin Hultcrantz, Jenna Rispoli, Oscar B Lahoud, Aisara Chansakul, Sydney X. Lu, Meghan Salcedo, Sham Mailankody, Francesco Maura, Neha Korde, Julia Schlossman, Allison Sams, Tala Shekarkhand, Elizabeth Tavitian, Kelly Werner, Even H Rustad, Amanda Ciardiello, Kazunori Murata, Caleb Ho, Victoria Diab, Urvi A Shah, Maria E. Arcila, David J. Chung, Heather Landau, Hani Hassoun, Katie Jones, Gunjan L. Shah, Sergio Giralt, Angela Harrison, Ola Landgren, Sean M. Devlin, Donna Mastey, Venkata Yellapantula, Mikhail Roshal, Eric L. Smith, Tim J Peterson, Alexander M. Lesokhin, Katie L. Thoren, Dennis Verducci, Lakshmi V. Ramanathan
Publikováno v:
Blood. 134:3127-3127
Background. Prior studies consistently show that the use of maintenance therapy after completion of combination therapy translates into longer progression-free survival (PFS) in patients with multiple myeloma. Some studies show that maintenance thera